STAT March 26, 2025
Brittany Trang

Using data from past trials, Altis Labs showed superior survival prediction in lung cancer patients

When AstraZeneca announced the results of its failed lung cancer immunotherapy trial in 2017, its stock plunged 16%. But that data was good for something — today, the drugmaker presented a re-evaluation of data from...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Clinical Trials, Pharma, Pharma / Biotech, Technology, Trends
From ChatGPT To Agent Networks: Why Your Company Needs A Multi-AI Strategy
AI's vibe-coding era: How the shift to apps changed the race
Worldwide spending on genAI to surge by hundreds of billions of dollars
Mission First: Pharma Should Partner, Not Build, Their AI Solutions
Web3 Is The Home For Autonomous Consumer AI Agents

Share This Article